Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118352215 | 11835221 | 5 | F | 2010 | 20160809 | 20151215 | 20160823 | EXP | GB-MHRA-ADR 22272189 | GB-ACCORD-036147 | ACCORD | 71.00 | YR | F | Y | 0.00000 | 20160823 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118352215 | 11835221 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 202553 | ||||||||||
| 118352215 | 11835221 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | ALSO RECEIVED 600 MG | U | B1010B08 | 0 | 450 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118352215 | 11835221 | 1 | Product used for unknown indication |
| 118352215 | 11835221 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118352215 | 11835221 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118352215 | 11835221 | Arthralgia | |
| 118352215 | 11835221 | Bladder irritation | |
| 118352215 | 11835221 | Blood pressure increased | |
| 118352215 | 11835221 | Dizziness | |
| 118352215 | 11835221 | Dry skin | |
| 118352215 | 11835221 | Dysuria | |
| 118352215 | 11835221 | Fall | |
| 118352215 | 11835221 | Fatigue | |
| 118352215 | 11835221 | Feeling abnormal | |
| 118352215 | 11835221 | Gingival pain | |
| 118352215 | 11835221 | Head injury | |
| 118352215 | 11835221 | Hepatic neoplasm | |
| 118352215 | 11835221 | Joint swelling | |
| 118352215 | 11835221 | Lacrimation increased | |
| 118352215 | 11835221 | Local swelling | |
| 118352215 | 11835221 | Musculoskeletal stiffness | |
| 118352215 | 11835221 | Myalgia | |
| 118352215 | 11835221 | Nasal congestion | |
| 118352215 | 11835221 | Neoplasm progression | |
| 118352215 | 11835221 | Onychoclasis | |
| 118352215 | 11835221 | Photophobia | |
| 118352215 | 11835221 | Pruritus | |
| 118352215 | 11835221 | Rhinorrhoea | |
| 118352215 | 11835221 | Sinus pain | |
| 118352215 | 11835221 | Skin abrasion | |
| 118352215 | 11835221 | Tenderness | |
| 118352215 | 11835221 | Trigeminal neuralgia | |
| 118352215 | 11835221 | Urinary retention | |
| 118352215 | 11835221 | Urine flow decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118352215 | 11835221 | 1 | 201509 | 0 | ||
| 118352215 | 11835221 | 2 | 2010 | 0 |